Annovis Intangible Assets vs Accounts Payable Analysis

ANVS Stock  USD 6.71  0.17  2.60%   
Annovis Bio financial indicator trend analysis is way more than just evaluating Annovis Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Annovis Bio is a good investment. Please check the relationship between Annovis Bio Intangible Assets and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Intangible Assets vs Accounts Payable

Intangible Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Annovis Bio Intangible Assets account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.
The correlation between Annovis Bio's Intangible Assets and Accounts Payable is 0.69. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Annovis Bio, assuming nothing else is changed. The correlation between historical values of Annovis Bio's Intangible Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Annovis Bio are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Intangible Assets i.e., Annovis Bio's Intangible Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.69
Relationship DirectionPositive 
Relationship StrengthSignificant

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Accounts Payable

An accounting item on the balance sheet that represents Annovis Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Annovis Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Annovis Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.Issuance Of Capital Stock is likely to gain to about 16.2 M in 2024, whereas Discontinued Operations is likely to drop (6.3 M) in 2024.
 2021 2022 2023 2024 (projected)
Research Development8.5M16.5M38.8M40.7M
Other Operating Expenses14.5M25.5M45.0M47.3M

Annovis Bio fundamental ratios Correlations

0.470.620.920.75-0.360.520.930.21-0.03-0.160.65-0.040.990.12-0.150.230.19-0.15-0.920.920.670.62-0.340.70.89
0.470.630.160.83-0.890.290.42-0.2-0.27-0.040.890.670.5-0.42-0.23-0.2-0.15-0.3-0.390.380.780.810.440.860.28
0.620.630.420.59-0.470.910.350.540.130.010.520.390.550.36-0.20.570.49-0.26-0.320.320.450.530.140.510.29
0.920.160.420.5-0.030.410.890.210.1-0.190.36-0.420.910.240.00.210.150.02-0.90.90.440.39-0.640.430.93
0.750.830.590.5-0.880.340.69-0.05-0.09-0.210.980.450.76-0.24-0.12-0.030.05-0.21-0.660.650.940.860.230.980.54
-0.36-0.89-0.47-0.03-0.88-0.18-0.310.150.170.12-0.93-0.75-0.370.430.20.150.060.320.27-0.26-0.84-0.8-0.61-0.89-0.12
0.520.290.910.410.34-0.180.190.820.360.020.220.190.410.69-0.130.850.76-0.16-0.170.160.180.220.030.210.16
0.930.420.350.890.69-0.310.19-0.11-0.24-0.140.63-0.120.97-0.15-0.15-0.1-0.14-0.13-1.01.00.680.63-0.450.70.97
0.21-0.20.540.21-0.050.150.82-0.110.52-0.07-0.18-0.030.090.81-0.20.980.82-0.220.12-0.12-0.2-0.21-0.02-0.19-0.11
-0.03-0.270.130.1-0.090.170.36-0.240.52-0.15-0.24-0.36-0.130.690.570.490.670.530.24-0.25-0.28-0.330.08-0.25-0.24
-0.16-0.040.01-0.19-0.210.120.02-0.14-0.07-0.15-0.170.13-0.16-0.07-0.08-0.06-0.11-0.060.15-0.14-0.180.20.07-0.17-0.14
0.650.890.520.360.98-0.930.220.63-0.18-0.24-0.170.560.67-0.39-0.18-0.17-0.09-0.27-0.60.590.950.890.321.00.47
-0.040.670.39-0.420.45-0.750.19-0.12-0.03-0.360.130.56-0.04-0.32-0.370.010.02-0.450.17-0.170.390.460.830.5-0.32
0.990.50.550.910.76-0.370.410.970.09-0.13-0.160.67-0.040.0-0.170.10.05-0.17-0.960.960.70.66-0.370.730.93
0.12-0.420.360.24-0.240.430.69-0.150.810.69-0.07-0.39-0.320.00.350.870.90.360.16-0.15-0.39-0.41-0.19-0.39-0.1
-0.15-0.23-0.20.0-0.120.2-0.13-0.15-0.20.57-0.08-0.18-0.37-0.170.35-0.110.270.980.14-0.14-0.2-0.220.0-0.18-0.12
0.23-0.20.570.21-0.030.150.85-0.10.980.49-0.06-0.170.010.10.87-0.110.88-0.130.12-0.12-0.18-0.2-0.01-0.17-0.1
0.19-0.150.490.150.050.060.76-0.140.820.67-0.11-0.090.020.050.90.270.880.260.16-0.17-0.13-0.210.14-0.1-0.18
-0.15-0.3-0.260.02-0.210.32-0.16-0.13-0.220.53-0.06-0.27-0.45-0.170.360.98-0.130.260.12-0.12-0.27-0.31-0.1-0.26-0.09
-0.92-0.39-0.32-0.9-0.660.27-0.17-1.00.120.240.15-0.60.17-0.960.160.140.120.160.12-1.0-0.65-0.610.48-0.67-0.98
0.920.380.320.90.65-0.260.161.0-0.12-0.25-0.140.59-0.170.96-0.15-0.14-0.12-0.17-0.12-1.00.640.61-0.490.660.98
0.670.780.450.440.94-0.840.180.68-0.2-0.28-0.180.950.390.7-0.39-0.2-0.18-0.13-0.27-0.650.640.890.10.960.56
0.620.810.530.390.86-0.80.220.63-0.21-0.330.20.890.460.66-0.41-0.22-0.2-0.21-0.31-0.610.610.890.150.90.52
-0.340.440.14-0.640.23-0.610.03-0.45-0.020.080.070.320.83-0.37-0.190.0-0.010.14-0.10.48-0.490.10.150.24-0.64
0.70.860.510.430.98-0.890.210.7-0.19-0.25-0.171.00.50.73-0.39-0.18-0.17-0.1-0.26-0.670.660.960.90.240.54
0.890.280.290.930.54-0.120.160.97-0.11-0.24-0.140.47-0.320.93-0.1-0.12-0.1-0.18-0.09-0.980.980.560.52-0.640.54
Click cells to compare fundamentals

Annovis Bio Account Relationship Matchups

Annovis Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1M8.1M46.0M36.0M10.2M14.9M
Other Current Liab776.9K236.5K818.4K3.7M3.0M3.1M
Total Current Liabilities2.0M578.4K1.5M7.7M4.3M3.0M
Total Stockholder Equity(8.6M)7.5M44.5M28.3M(7.8M)(7.4M)
Net Tangible Assets(7.6M)(8.6M)7.5M44.5M51.2M53.7M
Retained Earnings(8.8M)(14.2M)(28.7M)(54.1M)(110.3M)(104.7M)
Accounts Payable1.2M341.9K688.1K4.0M1.3M1.5M
Cash1.9K8.1M45.7M28.4M5.8M9.4M
Other Current Assets745.7M38.2K72.8K104.9K4.5M4.2M
Other Stockholder Equity200.6K21.8M73.2M82.4M102.5M107.6M
Total Liab9.7M578.4K1.5M7.7M18.0M18.9M
Total Current Assets747.5K8.1M46.0M36.0M10.2M12.9M
Net Debt497.9K(8.1M)(45.7M)(28.4M)(5.8M)(6.0M)
Cash And Short Term Investments1.9K8.1M45.7M28.4M5.8M5.5M
Common Stock Shares Outstanding6.8M6.3M7.6M8.2M9.0M7.3M
Liabilities And Stockholders Equity1.1M8.1M46.0M36.0M10.2M16.0M
Non Current Liabilities Total7.7M341.9K688.1K4.0M13.7M14.4M
Capital Surpluse192.1K200.6K21.8M73.2M84.2M88.4M
Net Invested Capital(8.1M)7.5M44.5M28.3M(7.8M)(7.4M)
Net Working Capital(1.3M)7.5M44.5M28.3M5.9M5.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.